Potential recombination between SARS-CoV-2 and MERS-CoV: calls for the development of Pan-CoV vaccines.Signal Transduct Target Ther. 2023 Mar 15; 8(1):122.ST
Links
MeSH
Pub Type(s)
Journal Article
Comment
Language
eng
PubMed ID
36922498
Citation
Wang, Qiao, et al. "Potential Recombination Between SARS-CoV-2 and MERS-CoV: Calls for the Development of Pan-CoV Vaccines." Signal Transduction and Targeted Therapy, vol. 8, no. 1, 2023, p. 122.
Wang Q, Sun L, Jiang S. Potential recombination between SARS-CoV-2 and MERS-CoV: calls for the development of Pan-CoV vaccines. Signal Transduct Target Ther. 2023;8(1):122.
Wang, Q., Sun, L., & Jiang, S. (2023). Potential recombination between SARS-CoV-2 and MERS-CoV: calls for the development of Pan-CoV vaccines. Signal Transduction and Targeted Therapy, 8(1), 122. https://doi.org/10.1038/s41392-023-01396-6
Wang Q, Sun L, Jiang S. Potential Recombination Between SARS-CoV-2 and MERS-CoV: Calls for the Development of Pan-CoV Vaccines. Signal Transduct Target Ther. 2023 Mar 15;8(1):122. PubMed PMID: 36922498.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Potential recombination between SARS-CoV-2 and MERS-CoV: calls for the development of Pan-CoV vaccines.
AU - Wang,Qiao,
AU - Sun,Lujia,
AU - Jiang,Shibo,
Y1 - 2023/03/15/
PY - 2023/1/20/received
PY - 2023/2/28/accepted
PY - 2023/2/20/revised
PY - 2023/3/16/entrez
PY - 2023/3/17/pubmed
PY - 2023/3/21/medline
SP - 122
EP - 122
JF - Signal transduction and targeted therapy
JO - Signal Transduct Target Ther
VL - 8
IS - 1
SN - 2059-3635
UR - https://www.unboundmedicine.com/medline/citation/36922498/Potential_recombination_between_SARS_CoV_2_and_MERS_CoV:_calls_for_the_development_of_Pan_CoV_vaccines_
DB - PRIME
DP - Unbound Medicine
ER -